- Home
- AIG vs EW Comparison
AIG vs EW Comparison
Compare AIG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIG
- EW
- Stock Information
- Founded
- AIG 1919
- EW 1958
- Country
- AIG United States
- EW United States
- Employees
- AIG N/A
- EW N/A
- Industry
- AIG Life Insurance
- EW Industrial Specialties
- Sector
- AIG Finance
- EW Health Care
- Exchange
- AIG Nasdaq
- EW Nasdaq
- Market Cap
- AIG 47.9B
- EW 40.7B
- IPO Year
- AIG N/A
- EW 2000
- Fundamental
- Price
- AIG $82.39
- EW $73.68
- Analyst Decision
- AIG Buy
- EW Buy
- Analyst Count
- AIG 15
- EW 20
- Target Price
- AIG $87.27
- EW $79.45
- AVG Volume (30 Days)
- AIG 3.9M
- EW 4.3M
- Earning Date
- AIG 05-01-2025
- EW 04-23-2025
- Dividend Yield
- AIG 2.19%
- EW N/A
- EPS Growth
- AIG N/A
- EW 201.77
- EPS
- AIG N/A
- EW 7.02
- Revenue
- AIG $27,047,000,000.00
- EW $5,522,300,000.00
- Revenue This Year
- AIG N/A
- EW $10.07
- Revenue Next Year
- AIG $5.06
- EW $9.65
- P/E Ratio
- AIG N/A
- EW $10.54
- Revenue Growth
- AIG N/A
- EW N/A
- 52 Week Low
- AIG $69.00
- EW $58.93
- 52 Week High
- AIG $88.07
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- AIG 51.82
- EW 52.18
- Support Level
- AIG $81.52
- EW $74.25
- Resistance Level
- AIG $84.10
- EW $76.13
- Average True Range (ATR)
- AIG 1.70
- EW 1.75
- MACD
- AIG 0.05
- EW -0.02
- Stochastic Oscillator
- AIG 69.73
- EW 56.51
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.